Chiba University study flags allergy risk in high-binding antibody drugs
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The primary goal of the collaboration is joint research into trending and next-generation molecules
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Subscribe To Our Newsletter & Stay Updated